2-Bromo-3,4-difluorobenzoic acid | CAS:170108-05-1

We serve 2-Bromo-3,4-difluorobenzoic acid CAS:170108-05-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Bromo-3,4-difluorobenzoic acid

Chemical Name:2-Bromo-3,4-difluorobenzoic acid
CAS.NO:170108-05-1
Synonyms:2-Bromo-3,4-difluorobenzoic acid
Molecular Formula:C7H3BrF2O2
Molecular Weight:236.99800
 
Physical and Chemical Properties:
Density:1.872;
Boiling point:292.9oC;
Flash point:131oC;
Index of Refraction:1.558;
 
Specification:
Appearance:Off white to faint peach powder
Purity(HPLC):≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate for organic synthesis



Contact us for information like 2-Bromo-3,4-difluorobenzoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Bromo-3,4-difluorobenzoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Bromo-3,4-difluorobenzoic acid Use and application,2-Bromo-3,4-difluorobenzoic acid technical grade,usp/ep/jp grade.


Related News: Developing countries such as China and India have good foundations for undertaking global industrial transfers because of their comparative advantages. With the continuous improvement of China’s fine chemical technology level, the types of products and market shares in China’s undertaking industrial transfer have gradually increased.methyl 2,3-difluoroisonicotinate manufacturer “And also to make sure that your meat is cooked thoroughly before consuming.”2-Bromo-5-fluorobenzaldehyde supplier Taiwan complained on Sunday that it was being punished because the World Health Organization considers it part of China, which has been subject to travel bans as the coronavirus spreads.6-fluoro-2-(oxiran-2-yl)-3,4-dihydro-2H-chromene vendor In recent years, with the increasing number of patent medicines whose patents have expired, the variety and quantity of generic drugs have also increased rapidly, which has brought huge market opportunities to the API market and the output of APIs has continued to increase.Beijing will strengthen its monitoring of overseas drug market and collect global prices for imported medicines, Friday’s guideline said.